| scholarly article | Q13442814 |
| P2093 | author name string | Jonathan D Berman | |
| P2860 | cites work | Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil | Q21034152 |
| Intermittent presumptive treatment for malaria | Q24809091 | ||
| Designing the next generation of medicines for malaria control and eradication | Q26859195 | ||
| Safety, tolerability, and compliance with long-term antimalarial chemoprophylaxis in American soldiers in Afghanistan | Q32944212 | ||
| Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects | Q33613720 | ||
| Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. | Q33999450 | ||
| Mefloquine induces dose-related neurological effects in a rat model | Q34509705 | ||
| Adult malaria chemoprophylaxis prescribing patterns in the military health system from 2007-2011 | Q37089620 | ||
| A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area. | Q37617688 | ||
| Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections | Q37707806 | ||
| Tafenoquine is not neurotoxic following supertherapeutic dosing in rats | Q38684922 | ||
| History of malaria in the United States Naval Forces at war: World War I through the Vietnam conflict | Q38898235 | ||
| Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic | Q40106428 | ||
| Chemosuppressive field trials in Thailand. IV. The suppression of Plasmodium falciparum and Plasmodium vivax parasitemias by mefloquine (WR 142,490, A 4-quinolinemethanol). | Q41926164 | ||
| Long-term malaria prophylaxis with weekly mefloquine | Q41937874 | ||
| Antimalarial drugs currently in development. | Q54364279 | ||
| Blood schizonticidal activity and safety of tafenoquine when administered as chemoprophylaxis to healthy, non-immune participants followed by blood stage Plasmodium falciparum challenge: A randomized, double-blinded, placebo-controlled Phase 1b study | Q58548302 | ||
| Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria | Q61920255 | ||
| Glucose-6-phosphate dehydrogenase deficiency | Q68175373 | ||
| Chemotherapy and chemoprophylaxis of malaria; clinical trials in 500 cases and mass prophylaxis in a hyperendemic area | Q75983665 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | malaria | Q12156 |
| parasitology | Q180502 | ||
| infectious disease | Q18123741 | ||
| P1104 | number of pages | 4 | |
| P304 | page(s) | 1301-1304 | |
| P577 | publication date | 2019-06-01 | |
| P1433 | published in | American Journal of Tropical Medicine and Hygiene | Q15766943 |
| P1476 | title | Approval of Tafenoquine for Malaria Chemoprophylaxis | |
| P478 | volume | 100 |
Search more.